Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.55 |
| ▸ | GPR132 | Q9UNW8 | 2/20 | 0.48 |
| ▸ | FAAH | O00519 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | CTSL | P07711 | 3/20 | 0.46 |
| ▸ | CTSB | P07858 | 3/20 | 0.46 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.46 |
| ▸ | NAMPT | P43490 | 1/20 | 0.46 |
| ▸ | CASP1 | P29466 | 1/20 | 0.45 |
| ▸ | CASP3 | P42574 | 1/20 | 0.45 |
| ▸ | CASP7 | P55210 | 1/20 | 0.45 |
| ▸ | CASP6 | P55212 | 1/20 | 0.45 |
| ▸ | CASP8 | Q14790 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6447557 | 0.88 | ALDH1A1 (0.55) | CYP3A4GPR132FAAHALDH1A1MEN1 | |
| SCHEMBL7269609 | 0.88 | GPR132 (0.61) | CYP3A4GPR132ALDH1A1MEN1LMNA | |
| SCHEMBL7269614 | 0.88 | GPR132 (0.61) | CYP3A4GPR132ALDH1A1MEN1LMNA | |
| SCHEMBL6447561 | 0.88 | ALDH1A1 (0.55) | CYP3A4GPR132FAAHALDH1A1MEN1 | |
| SCHEMBL12330200 | 0.88 | CYP3A4 (0.55) | CYP3A4GPR132FAAHALDH1A1MEN1 | |
| SCHEMBL6446200 | 0.86 | GPR132 (0.60) | CYP3A4GPR132ALDH1A1MEN1LMNA | |
| SCHEMBL6446192 | 0.86 | GPR132 (0.60) | CYP3A4GPR132ALDH1A1MEN1LMNA | |
| Lithium Ion SCHEMBL6446195 | 0.85 | CYP3A4 (0.53) | CYP3A4GPR132FAAHALDH1A1MEN1 | |
| SCHEMBL8219125 | 0.84 | CTSL (0.59) | CYP3A4MEN1LMNAKMT2ACTSL | |
| SCHEMBL8219127 | 0.84 | CTSL (0.59) | CYP3A4MEN1LMNAKMT2ACTSL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100272681-A1 | Inhibitors of Serine Proteases | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2010-10-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100272681-A1 | Inhibitors of Serine Proteases | SERPINB1, PRSS1, SPINT2 | CYP3A4 527/4885GPR132 3590/4885FAAH 1206/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.